Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus--a prospective pilot study

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Low-dose rituximab in adult patients with primary immune thrombocytopenia

(2010) Francesco Zaja et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe?

(2009) W J Zheng et al.   ANNALS OF THE RHEUMATIC DISEASES

Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus

(2009) J-W. Lee et al.   LUPUS

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

(2008) F. Zaja et al.   HAEMATOLOGICA

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

B-Cell Depletion for Autoimmune Thrombocytopenia and Autoimmune Hemolytic Anemia in Pediatric Systemic Lupus Erythematosus

(2008) S. Kumar et al.   PEDIATRICS

Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus

(2008) K. Suzuki et al.   RHEUMATOLOGY

Letter to the Editor

(2007) N. Limal et al.   LUPUS